Objectives To identify what changes in the prescribing of isotretinoin have occurred since funded prescriber access was widened in 2009 from ‘dermatologist only’ prescribing to include ‘general ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback